Antibacterial Agents TRIZ Cases

Merges hydrolysis and substitution in water to eliminate organic solvents, reduce position isomers, and achieve yields above 90%.

Adsorbing antigens onto negatively charged spores at controlled pH resolves alum adjuvant limitations while ensuring stable immune response induction.

New DDAH-1 inhibitors remove the alpha-carboxyl group to improve oral bioavailability.

Composite probiotic formulation restores intestinal balance to reduce recurrence rates while avoiding fecal transplant standardization issues.

Mining the human proteome reveals encrypted peptides that kill pathogens via membrane disruption, bypassing traditional resistance mechanisms.

Isolated Bacillus subtilis 3 strain eliminates respiratory tract pathogens via specific growth inhibition while maintaining high safety profiles.

Pyrroline-dione derivatives inhibit tumor necrosis factor alpha release, offering a low-toxicity alternative to expensive antibody treatments.

Non-solid topical compositions containing Lactobacillus strains compete with pathogens to treat infections without triggering antifungal resistance.

Allogeneic Natural Killer cells reduce inflammatory cytokines and increase anti-inflammatory markers to resolve sepsis-induced organ damage.

Harungana madagascariensis leaf extract inhibits Propionibacterium acnes bacteria and reduces inflammation through polyphenolic compounds.

Styryl quinazoline derivatives inhibit FLT3 ITD kinase activity while exhibiting bactericidal action against pathogenic bacteria.

Modifying the sisomicin structure creates derivatives that bind bacterial RNA, resolving antibiotic resistance by inhibiting translation.

Extracting specific anti-tetanus antibodies eliminates lot variability and adverse reactions caused by bulk protein administration.

Prebiotic carbohydrates trigger spore germination in the gut, increasing viable bacterial titer despite stomach acidity.

Self-assembling amphiphilic peptide formulations create thermally stable hydrogels for targeted medical applications.

Combining pegylated IL-10 with ADCC antibodies enhances NK cell activity.

Modified ammonium compounds overcome reduced efficacy in biofilms by combining quaternary amine structures with acid moieties to treat bacterial infections.

Monochlorourea reduces corrosion and material degradation by limiting non-specific reactions with non-biological components.

Cholesterol-bearing pullulan nanogel induces systemic and mucosal immunity without harmful adjuvants.

Replacing toxic organic solvents, the hydroalcoholic vehicle improves nail penetration while reducing toxicity and irritation.

Small molecule compounds inhibit PD-L1 binding to restore T cell function, overcoming stability and toxicity limits of monoclonal antibodies.

A topical composition combining niacin and hydrogen peroxide to promote blood vessel dilation and accelerate clotting.

Fusing a membrane-permeating peptide with an endolysin variant enables enzymatic hydrolysis of the Gram-negative bacterial cell wall.

Final-stage silver(I)-promoted oxidative dimerization constructs the C5-C5′ biaryl linkage, resolving synthetic efficiency and antibiotic activity trade-offs.

Pyrrolo[2,3-d]pyrimidine derivatives overcome blood-brain barrier limits to treat neurological disorders via selective JAK1 inhibition.

Selective CRISPR-mediated reduction of pathogenic gut bacteria enhances immune checkpoint inhibitor efficacy while minimizing systemic toxicity.

Poplar bud extracts replace propolis with comparable mucoadhesive strength and antibacterial activity while eliminating allergenic bee-derived substances.

Modified antimicrobial peptides segregate to coating surfaces, reducing toxicity while maintaining bacterial activity.

Albumin binds PCV2 immunogen to prevent interference with live attenuated PRRS virus, maintaining viability and serological response.

CpG-DNA stimulates B cells to produce specific monoclonal antibodies that clear MRSA bacteria and increase survival rates in immune-suppressed patients.

Nitric oxide donor nanoparticles combine with antimicrobial agents to overcome antibiotic resistance while reducing dosage requirements.

Novel compounds inhibit cytochrome bc1 and ATP synthase in Mycobacterium tuberculosis to disrupt bacterial energy production.

Novel bicyclic compounds target bacterial methionyl tRNA synthetase to overcome antibiotic resistance in Clostridium difficile infections.

Substituted thiophene compounds inhibit HCV polymerase to improve sustained viral response while reducing side effects.

Recombinant chimeric polypeptides derived from Staphylococcus aureus proteins function as immunogens to induce protective adaptive immunity.

Aluminum oxide adjuvants preserve trans-sialidase enzymatic activity while recombinant polynucleotides enable MHC class I pathway entry for protective immunity.

Dose-reduced inactivated polio virus antigens adsorbed on aluminum hydroxide maintain immunogenicity within a stable multivalent vaccine formulation.

An O/W emulsion encapsulates water-insoluble drugs using specific lipids to maintain sub-100 nm particle size.

Quindoline derivatives maintain a positively charged quaternary N-5 atom to enhance cellular penetration and pharmacological effectiveness.

Nitrogen atmosphere prevents oxidation during in situ conversion, ensuring chemical stability and finer particle size.

Pyridopyrimidine derivatives inhibit phosphodiesterase 4, reducing emetic side effects while maintaining anti-inflammatory efficacy.

Phosphorothioate modifications on short double-stranded RNAi constructs enhance stability in biological fluids while maintaining potent gene silencing efficacy.

Recombinant OmpB fragments improve diagnostic accuracy and standardization while removing BSL-3 containment requirements.

Chemical modifications at the 7 and 9 positions create narrow-spectrum agents that overcome antibiotic resistance in Bacillus anthracis strains.

Alcanivorax dieselolei T6-6 degrades petroleum hydrocarbons and produces stable lipopeptide biosurfactants.